While at ASH 2024, Lauren Peres, PhD highlighted racial and ethnic differences in outcomes of #MultipleMyeloma patients treated with idecabtagene vicleucel or ciltacabtagene autoleucel.
Read more: [ Ссылка ]
Ещё видео!
While at ASH 2024, Lauren Peres, PhD highlighted racial and ethnic differences in outcomes of #MultipleMyeloma patients treated with idecabtagene vicleucel or ciltacabtagene autoleucel.
Read more: [ Ссылка ]